Liver Transplantation
Surgical strategy devised for HVOB after living-donor transplants
Published in Hepatitis Weekly, August 9th, 2004
"The incidence of hepatic venous complications in partial liver transplantation is more frequent than that in whole liver transplantation," scientists in Japan explained. "There are no reports of a surgical strategy for hepatic venous outflow block (HVOB) after living-donor liver transplantation."
"HVOB was diagnosed when the pull-through pressure gradient across the anastomotic site was over 5 mm Hg," in patients treated by N. Akamatsu and colleagues at the University of Tokyo. "Reoperation for venous anastomosis was performed if the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-08-09)
More Articles from Hepatitis Weekly
- Adverse Drug Effects
Breath carbon monoxide measures the effects of ribavirin on red blood cells - Chronic Hepatitis C
Black American patients with HCV genotype 1 respond to combination therapy - Chronic Liver Disease
DDB cloaks the true effects of new drugs on liver enzyme levels - Chronic Viral Hepatitis
Pegylated interferon prevents the chronicity of hepatitis C virus infection - Drug Development
Phosphorothioate di- and trinucleotides abate hepatitis B virus replication - Adenosquamous Cancer
Hepatic ASC treated with TACE using degradable starch microspheres - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
